The Evolution of Population Health Models: A Healthcare Technology Perspective for 2026 and Beyond

This IDC Market Perspective provides healthcare technology suppliers with a strategic framework for navigating the 2026-2030 landscape. The U.S. healthcare system is experiencing a decisive shift from value-based care experimentation to scaled, sustained accountability. Beginning in 2026 and accelerating through 2030, CMS (Centers for Medicare and Medicaid Services) is deploying a coordinated portfolio of mandatory and voluntary population health models, TEAM (Transforming Episode Accountability Model), LEAD (Long-term Enhanced ACO Design), ACCESS (Advancing Chronic Care with Effective, Scalable Solutions), and MAHA ELEVATE (Make America Health Again: Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence), that together create comprehensive financial pressure across surgical episodes, total cost of care, and chronic disease management.For healthcare technology suppliers, this transition represents both a market inflection point and a strategic imperative. The era of selling point solutions to willing pilot participants is ending. In its place, mandatory participation models, 10-year performance horizons, and flat-to-negative Medicare Advantage payment growth force providers and payers to operationalize value-based care at enterprise scale or face unsustainable margin erosion."Value-based care's evolving payment models aren't just changing contracts; they're rewriting the tech brief. When revenue depends on episodes, outcomes, and engagement, health systems don't need more apps; they need a connected stack that can see across models, prove impact in real time, and keep evolving without fracturing compliance." - Jennifer Eaton, research director, Value-Based Healthcare IT Transformation Strategies.